Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
出版年份 2020 全文链接
标题
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
作者
关键词
-
出版物
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-02-28
DOI
10.1038/s41386-020-0644-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Caution Against Overinterpreting Opiate Receptor Stimulation as Mediating Antidepressant Effects of Ketamine
- (2019) Gerard Sanacora AMERICAN JOURNAL OF PSYCHIATRY
- Molecular basis for class side effects associated with PI3K/AKT/mTOR pathway inhibitors
- (2019) Ying Zhang et al. Expert Opinion on Drug Metabolism & Toxicology
- Mood-stabilizing effects of rapamycin and its analog temsirolimus
- (2018) Nirit Z. Kara et al. BEHAVIOURAL PHARMACOLOGY
- Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
- (2018) Allison C. Nugent et al. MOLECULAR PSYCHIATRY
- The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
- (2018) Chadi G. Abdallah et al. PHARMACOLOGY & THERAPEUTICS
- The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder
- (2018) Chadi G. Abdallah et al. Annual Review of Pharmacology and Toxicology
- Antidepressants act by inducing autophagy controlled by sphingomyelin–ceramide
- (2018) Anne Gulbins et al. MOLECULAR PSYCHIATRY
- Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
- (2018) Todd D. Gould et al. Annual Review of Pharmacology and Toxicology
- Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder
- (2017) B Kadriu et al. MOLECULAR PSYCHIATRY
- Targeting glutamate signalling in depression: progress and prospects
- (2017) James W. Murrough et al. NATURE REVIEWS DRUG DISCOVERY
- The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
- (2017) Chadi G Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antinociceptive and Anti-Inflammatory Effects of Ketamine and the Relationship to Its Antidepressant Action and GSK3 Inhibition
- (2016) Eduardo Mulato do Vale et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs
- (2016) Zuleide M. Ignácio et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation
- (2016) M M Harraz et al. MOLECULAR PSYCHIATRY
- Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
- (2016) Andrew H Miller et al. NEUROPSYCHOPHARMACOLOGY
- Inflammation, Glutamate and Glia: A Trio of Trouble in Mood Disorders
- (2016) Ebrahim Haroon et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine as a promising prototype for a new generation of rapid-acting antidepressants
- (2015) Chadi G. Abdallah et al. Annals of the New York Academy of Sciences
- Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression
- (2015) Bruno Romeo et al. PSYCHIATRY RESEARCH
- The positive effect on ketamine as a priming adjuvant in antidepressant treatment
- (2015) A Melo et al. Translational Psychiatry
- Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects
- (2014) Ole Köhler et al. JAMA Psychiatry
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
- (2013) W. Zhou et al. EUROPEAN PSYCHIATRY
- Conceptual Confluence: The Kynurenine Pathway as a Common Target for Ketamine and the Convergence of the Inflammation and Glutamate Hypotheses of Depression
- (2013) Andrew H Miller NEUROPSYCHOPHARMACOLOGY
- NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
- (2013) Adam K Walker et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine for Depression: Where Do We Go from Here?
- (2012) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test
- (2012) Chun Yang et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling
- (2011) Smita Majumder et al. AGING CELL
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism
- (2010) Sven Gottschalk et al. NEUROTOXICOLOGY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders
- (2008) C. Cleary et al. BRAIN RESEARCH BULLETIN
- Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma
- (2008) Tim F Cloughesy et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now